5-membered heteroaryl carboxamide compounds for treatment of HBV

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12030869
APP PUB NO 20240150324A1
SERIAL NO

17989237

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASSEMBLY BIOSCIENCES INC11711 NORTH MERIDIAN STREET SUITE 310 CARMEL IN 46032

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bannen, Lynne South San Francisco, US 7 0
Bures, Mark G South San Francisco, US 9 1
Haydar, Simon Nicolas South San Francisco, US 14 6
Li, Leping South San Francisco, US 119 2017
Rai, Roopa South San Francisco, US 54 414
Walker, Michael South San Francisco, US 148 2584

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 9, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 9, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00